Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973141-24-000581
Filing Date
2024-11-27
Accepted
2024-11-27 16:06:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2982
  Complete submission text file 0001973141-24-000581.txt   4575
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Subject) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36407 | Film No.: 241511071
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036
Business Address
Fitzgerald Kevin Joseph (Reporting) CIK: 0001886431 (see all company filings)

Type: 144